白宫新的毒品计划以类阿片滥用和获得治疗为目标,但因忽视更广泛的吸毒成瘾问题和长期供资而面临批评。 The White House's new drug plan targets opioid misuse and treatment access but faces criticism for ignoring broader addiction issues and long-term funding.

白宫的新药物计划侧重于减少处方类阿片滥用和扩大治疗机会,但批评者指出,该计划忽略了更为广泛的系统性问题,如非法药物使用增加以及恢复方案缺乏长期资金。 The White House's new drug plan focuses on reducing prescription opioid misuse and expanding access to treatment, but critics note it overlooks broader systemic issues like the rising use of illicit drugs and the lack of long-term funding for recovery programs. 虽然该计划强调预防和执行,但它在解决吸毒成瘾的根源或支持受影响最严重的社区方面提供的细节有限。 While the plan emphasizes prevention and enforcement, it provides limited detail on addressing the root causes of addiction or supporting communities most affected. 一些专家认为,该战略缺乏具体措施,无法追究制药公司的责任或确保农村和城市地区公平获得护理。 Some experts argue the strategy lacks concrete measures to hold pharmaceutical companies accountable or ensure equitable access to care across rural and urban areas.